Pharmalittle: We're reading about an FDA panel and peptides, a Merck license for an HIV pill, and more

UPDATE: Peptides favored on 1st day of closely watched FDA compounding adcomm

An FDA advisory committee has recommended that three peptide drugs that were previously restricted because of potential safety concerns be restored to the 503A Bulk Drug Substances list, which woul | An FDA advisory…